This topic contains a solution. Click here to go to the answer

Author Question: How does noninvasive ventilation (NIV) benefit the patient with restrictive thoracic disease? 1. It ... (Read 55 times)

NClaborn

  • Hero Member
  • *****
  • Posts: 560
How does noninvasive ventilation (NIV) benefit the patient with restrictive thoracic disease? 1. It rests the respiratory muscles. 2. It lowers the PaCO2. 3. It improves lung compliance. 4. It improves pulmonary function testing.
 
  a. 1, 2, and 3 only
  b. 2 and 4 only
  c. 1, 2, and 4 only
  d. 1, 3, and 4 only

Question 2

Which of the following are benefits of continuous positive airway pressure (CPAP) in postopera-tive major abdominal surgery? 1. Lower mortality 2. Lower intubation rate 3. Lower incidence of pneumonia 4. Lower rate of sepsis
 
  a. 1 and 3 only
  b. 1, 2, and 3 only
  c. 3 and 4 only
  d. 2, 3, and 4 only



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

shaikhs

  • Sr. Member
  • ****
  • Posts: 312
Answer to Question 1

ANS: A
The first mechanism is the ability of NIV to rest the respiratory muscles. Second, NIV lowers the PaCO2, and the decrease is believed to reset the central ventilatory controller and establish a new baseline PaCO2. The third mechanism is the improvement in lung compliance, lung volume, and dead space that result from NIV.

Answer to Question 2

ANS: D
The CPAP group had a lower rate of intubation, pneumonia, overall infection, and sepsis.




NClaborn

  • Member
  • Posts: 560
Reply 2 on: Jul 16, 2018
:D TYSM


nathang24

  • Member
  • Posts: 314
Reply 3 on: Yesterday
Excellent

 

Did you know?

A seasonal flu vaccine is the best way to reduce the chances you will get seasonal influenza and spread it to others.

Did you know?

The U.S. Pharmacopeia Medication Errors Reporting Program states that approximately 50% of all medication errors involve insulin.

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

Vaccines prevent between 2.5 and 4 million deaths every year.

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

For a complete list of videos, visit our video library